⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6120215 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL29865271 | 0.98 | ALOX15 (0.37) | — | |
| SCHEMBL29638859 | 0.98 | ALOX15 (0.37) | — | |
| Phosphoric Acid SCHEMBL214831 | 0.88 | ESR1 (0.35) | — | |
| SCHEMBL3209106 | 0.85 | NOTUM (0.36) | — | |
| Pyrophosphoric Acid SCHEMBL214830 | 0.82 | ESR1 (0.33) | — | |
| SCHEMBL3172872 | 0.79 | — | — | |
| SCHEMBL15935167 | 0.71 | — | — | |
| SCHEMBL12609857 | 0.69 | RET (0.40) | — | |
| SCHEMBL15601539 | 0.67 | AHR (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250019373-A1 | ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF KINASE-RELATED DISEASES | VORONOI INC. (KR) | 2025-01-16 | — | — | US | claimed |
| CN-118894816-A | 3, 3-Difluoroallylamine or salt thereof and pharmaceutical composition comprising the same | 柳韩洋行 | 2024-11-05 | — | — | CN | claimed |
| EP-4421077-A1 | ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF KINASE-RELATED DISEASES | Voronoi Inc. (KR) | 2024-08-28 | — | — | EP | claimed |
| CN-118475578-A | Aryl or heteroaryl derivatives for preventing or treating kinase-related diseases and pharmaceutical compositions containing the same as active ingredient | 沃若诺伊公司 | 2024-08-09 | — | — | CN | claimed |
| US-20240239799-A1 | (S)-1-(5-((PYRIDIN-3-YL)THIO)PYRAZIN-2-YL)-4'H,6'H-SPIRO[PIPERIDINE-4,5'-PYRROLO [1,2-B]PYRAZOL]-4'-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS SHP2 INHIBITORS FOR THE TREATMENT OF E.G. CANCER | C.N.C.C.S. S.C.A.R.L. COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING (IT) | 2024-07-18 | — | — | US | claimed |
| EP-4347040-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF CANCER | Petra Pharma Corporation (US) | 2024-04-10 | — | — | EP | claimed |
| WO-2024068976-A1 | AZOLE DERIVATIVES AS SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2024-04-04 | — | — | WO | claimed |
| EP-4345101-A1 | AZOLE DERIVATIVES AS SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2024-04-03 | — | — | EP | claimed |
| US-20240051956-A1 | SOS1 INHIBITORS AND USES THEREOF | QILU REGOR THERAPEUTICS INC. (CN) | 2024-02-15 | — | — | US | claimed |
| EP-4313983-A1 | (S)-1-(5-((PYRIDIN-3-YL)THIO)PYRAZIN-2-YL)-4'H,6'H-SPIRO[PIPERIDINE-4,5'-PYRROLO [1,2-B]PYRAZOL]-4'-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS SHP2 INHIBITORS FOR THE TREATMENT OF E.G. CANCER | C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening (IT) | 2024-02-07 | — | — | EP | claimed |
| WO-2013005187-A1 | METHOD FOR PREPARING METAL-FREE NITROGEN-CONTAINING CARBON NANOTUBES | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2013-01-10 | — | — | WO | claimed |
| EP-2543631-A1 | Method for preparing metal-free nitrogen-containing carbon nanotubes | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2013-01-09 | — | — | EP | claimed |
| EP-1474139-B1 | 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES, OBESITY AND DYSLIPIDEMIA | MERCK & CO INC (US) | 2007-11-21 | — | — | EP | claimed |
| EP-1494650-A4 | PHARMACEUTICAL FORMULATION COMPRISING MELATONIN | NEURIM PHARMA 1991 (IL) | 2006-07-12 | — | — | EP | claimed |
| US-20050175692-A1 | For use in short-term potentiation of the effects of non-barbiturate and non-benzodiazepine hypnotics such as zaleplon, zolpidem, zopiclone and trazodone on sedation and psychomotor skills; prevents drug dependence | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2005-08-11 | — | — | US | claimed |
| EP-1494650-A1 | PHARMACEUTICAL FORMULATION COMPRISING MELATONIN | NEURIM PHARMACEUTICALS (1991) LIMITED (IL) | 2005-01-12 | — | — | EP | claimed |
| WO-2003086352-A1 | PHARMACEUTICAL FORMULATION COMPRISING MELATONIN | NEURIM PHARMACEUTICALS (1991) LTD. (IL) | 2003-10-23 | — | — | WO | claimed |
| EP-0745154-B1 | MULTICOMPONENT SYSTEM FOR MODIFYING, DECOMPOSING OR BLEACHING LIGNIN, LIGNIN-CONTAINING MATERIALS OR SIMILAR SUBSTANCES AND METHOD OF USING THIS SYSTEM | LIGNOZYM GMBH (DE) | 1998-09-16 | — | — | EP | claimed |
| EP-0845026-A1 | MULTICOMPONENT SYSTEM FOR USE WITH DETERGENT SUBSTANCES | CALL, Hans-Peter Dr. (DE) | 1998-06-03 | — | — | EP | claimed |
| WO-1997048786-A1 | MULTICOMPONENT SYSTEM FOR USE WITH DETERGENT SUBSTANCES | CALL HANS PETER (DE) | 1997-12-24 | — | — | WO | claimed |